AAO Digital GUIDELINES Apps (free trial)

AAO Primary Open Angle Glaucoma Suspect

AAO GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/735438

Contents of this Issue

Navigation

Page 5 of 11

Management Breast-feeding Î Brimonidine is known to cross the blood-brain barrier and can cause apnea in infants. For this reason, it is usually recommended that brimonidine NOT be used in mothers who are breast-feeding. (III, G, S) Follow-up Evaluation Î Primary open-angle glaucoma suspect patients who are being observed should be seen at least every 12 to 24 months, depending on individual risk factors. (G, S) Adjustment of Therapy Î In glaucoma suspect patients, decisions for therapeutic intervention should aim to minimize risks from treatment, whereas in POAG, the decision to treat aims to minimize the risks of glaucoma disease progression. (G, S) 4 The indications for adjusting therapy in glaucoma suspect patients are as follows: • Target IOP is not achieved and the benefits of a change in therapy outweigh the risks for the patient • The patient is intolerant of the prescribed medical regimen • The patient does not adhere to the prescribed medical regimen • Contraindications to individual medicines develop • The patient under treatment has been stable for a prolonged period without progression to POAG. In this case, cautious withdrawal of therapy may be considered. Counseling And Referral Î Patients should be educated about their condition and its potential to lead to the blinding disease glaucoma, the rationale and goals of intervention, the status of their condition, and the relative benefits and risks of alternative interventions so that they can participate meaningfully in developing an appropriate plan of action. (G, S) Î Patients should be encouraged to alert their ophthalmologist to physical or emotional changes that occur when taking glaucoma medications, if prescribed. (G, S) Î Patients considering keratorefractive surgery should be informed about the possible impact laser vision correction has on reducing contrast sensitivity and decreasing the accuracy of lOP measurements. (G, S)

Articles in this issue

Archives of this issue

view archives of AAO Digital GUIDELINES Apps (free trial) - AAO Primary Open Angle Glaucoma Suspect